T
Toshiyuki Ogata
Researcher at Osaka University
Publications - 30
Citations - 892
Toshiyuki Ogata is an academic researcher from Osaka University. The author has contributed to research in topics: Brachytherapy & High-Dose Rate Brachytherapy. The author has an hindex of 15, co-authored 30 publications receiving 813 citations. Previous affiliations of Toshiyuki Ogata include Kyoto Prefectural University of Medicine & Kyoto Prefectural University.
Papers
More filters
Journal Article
Particle Irradiation Suppresses Metastatic Potential of Cancer Cells
Toshiyuki Ogata,Teruki Teshima,Kazufumi Kagawa,Yoshio Hishikawa,Yutaka Takahashi,Atsuko Kawaguchi,Yuko Suzumoto,Kumie Nojima,Yoshiya Furusawa,Nariaki Matsuura +9 more
TL;DR: It is suggested that particle irradiation suppresses metastatic potential even at lower doses, whereas photon irradiation promotes cell migration and invasive capabilities at lower dose level, and preclinical evidence that ion beam radiotherapy may be superior to conventional photon beam therapy in possible preventive effects on metastases of irradiated malignant tumor cells is provided.
Journal ArticleDOI
Recent Advances in the Biology of Heavy-Ion Cancer Therapy
Nobuyuki Hamada,Tatsuhiko Imaoka,Shin-ichiro Masunaga,Toshiyuki Ogata,Ryuichi Okayasu,Akihisa Takahashi,Takamitsu A. Kato,Yasuhiko Kobayashi,Takeo Ohnishi,Koji Ono,Yoshiya Shimada,Teruki Teshima +11 more
TL;DR: This paper briefly reviews the current knowledge of the biological aspects of heavy-ion therapy, and focuses on the authors' recent findings on repair mechanisms of heavy ion-induced DNA damage.
Journal ArticleDOI
Monotherapeutic high-dose-rate brachytherapy for prostate cancer: Five-year results of an extreme hypofractionation regimen with 54 GY in nine fractions
Yasuo Yoshioka,Koji Konishi,Iori Sumida,Yutaka Takahashi,Fumiaki Isohashi,Toshiyuki Ogata,Masahiko Koizumi,Hideya Yamazaki,Norio Nonomura,Akihiko Okuyama,Takehiro Inoue +10 more
TL;DR: Monotherapeutic HDR brachytherapy with an extreme hypofractionation regimen of 54 Gy in nine fractions associated with hormonal therapy was feasible, and its toxicity was acceptable, even for patients with locally advanced disease.
Journal Article
Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose.
Yutaka Takahashi,Teruki Teshima,Naomasa Kawaguchi,Yoshinosuke Hamada,Seiji Mori,Ayako Madachi,Satoko Ikeda,Hirokazu Mizuno,Toshiyuki Ogata,Kumie Nojima,Yoshiya Furusawa,Nariaki Matsuura +11 more
TL;DR: It is found that in vitro angiogenesis was inhibited by high linear energy transfer carbon ion irradiation even at sublethal dose (0.1 Gy), providing an implication that heavy ion beam therapy could be superior to conventional photon beam therapy in preventive effects on in vitroAngiogenesis even atSublethal dose, and might inhibit angiogenic in vivo.
Journal ArticleDOI
Carbon Ion Irradiation Suppresses Metastatic Potential of Human Non-small Cell Lung Cancer A549 Cells through the Phosphatidylinositol-3-Kinase/Akt Signaling Pathway
Toshiyuki Ogata,Teruki Teshima,Miho Inaoka,Kazumasa Minami,Takahiro Tsuchiya,Masaru Isono,Yoshiya Furusawa,Nariaki Matsuura +7 more
TL;DR: The results suggest that carbon ion irradiation effectively suppresses the metastatic potential of A549 cells by suppressing the PI3K/Akt signaling pathway.